ArticleBMC pregnancy and childbirth2026
Longitudinal metabolomics reveals dynamic associations of trimethylamine N-oxide and precursors with the progression of gestational diabetes.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundTrimethylamine N-oxide (TMAO) and its precursor metabolites are strongly linked to glucose and lipid metabolic disorders, yet their dynamic roles and overall effects in gestational diabetes mellitus (GDM) have not been clarified. We aimed to explore the dynamic patterns of change and the overall effects of the six TMAO-related metabolites (including Trimethylamine N-oxide, Trimethylamine, choline, L-carnitine, betaine and creatinine) in relation to GDM.
methodsA total of 180 serum samples from a nested case–control study were analyzed via targeted metabolomics covering early, middle, and late pregnancy. Conditional logistic regression, Bayesian kernel-machine regression (BKMR), weighted quantile sum regression (WQS) and quantile g-computation regression (QGC) were employed to characterize the dynamic associations and mixture patterns of TMAO-related metabolites with GDM risk.
resultsGDM patients exhibited progressive decreases in L-carnitine, alongside elevations in choline and trimethylamine. Early-pregnancy L-carnitine levels were positively associated with GDM. BKMR showed positive, U-shaped and negative associations between TMAO-related metabolites and GDM in three trimesters, respectively. L-carnitine and trimethylamine demonstrated positive associations with GDM during the first trimester. Choline exhibited a shift from negative to positive associations and showed potential interaction patterns with L-carnitine in the second and third trimesters. WQS showed L-carnitine and trimethylamine presenting higher weight in the first and third trimester, respectively. QGC further validated a mixture effect in the third trimester, primarily attributed to trimethylamine and choline.
conclusionsThe associations of L-carnitine, trimethylamine and choline with GDM demonstrated dynamic temporal patterns throughout pregnancy.These findings may provide insight into trimester-specific metabolic variation in GDM, but should be considered exploratory and require validation in larger cohorts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.